BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa Read more
CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease Read more